Khemani Distributors & Marketing Limited (BOM:539788)
132.90
+4.90 (3.83%)
At close: Dec 19, 2025
BOM:539788 Revenue
Khemani Distributors & Marketing had revenue of 578.93M INR in the half year ending September 30, 2025, a decrease of -13.18%. This brings the company's revenue in the last twelve months to 1.09B, up 26.09% year-over-year. In the fiscal year ending March 31, 2025, Khemani Distributors & Marketing had annual revenue of 921.18M, down -17.72%.
Revenue (ttm)
1.09B
Revenue Growth
+26.09%
P/S Ratio
2.80
Revenue / Employee
45.38M
Employees
24
Market Cap
3.05B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 921.18M | -198.39M | -17.72% |
| Mar 31, 2024 | 1.12B | 305.84M | 37.58% |
| Mar 31, 2023 | 813.74M | 125.18M | 18.18% |
| Mar 31, 2022 | 688.56M | 75.50M | 12.31% |
| Mar 31, 2021 | 613.06M | 308.71M | 101.44% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Remus Pharmaceuticals | 7.48B |
| Chemkart India | 1.93B |
| Rama Vision | 1.34B |
| Checkpoint Trends | 1.21B |
| VijayPD Ceutical | 1.07B |
| Vaidya Sane Ayurved Laboratories | 979.90M |
| Novelix Pharmaceuticals | 849.03M |
| Medico Intercontinental | 822.95M |